Tag

Alzheimers Disease

Editorial ArticleLife Sciences

7 life sciences trends to watch in 2026

From AI to aging science, experts share their predictions on the technologies and discoveries set to shape life sciences in 2026

22 Jan 2026

Industry NewsClinical Diagnostics

Thermo Fisher Scientific enrols first patient in the new PPD CorEvitas Alzheimer’s Disease Registry

6 Jan 2026

Product NewsDrug discovery > Clinical Development

Alzamend Neuro's AL001 formulation highlights its potential to treat disorders such a Alzheimer's

25 Nov 2025

Editorial ArticleClinical Diagnostics

AI and the rise of blood-based biomarkers heralds new era for neurological diagnostics

8 Oct 2025

Webinars

Enhanced early Alzheimer's detection via ultra‑sensitive plasma pTau 217 measurement

Available on-demand

Advancing next-generation proteomics with single-molecule Iterative Mapping

Available on-demand

Rethinking neurodegeneration through blood-based biomarkers

Available on-demand

Bringing the proteome into focus with single-molecule proteome and proteoform analysis

Available on-demand

Editorial Articles

7 life sciences trends to watch in 2026

22 Jan 2026

Lindsey Mette, Director of Medical Affairs, Quanterix

AI and the rise of blood-based biomarkers heralds new era for neurological diagnostics

8 Oct 2025

New lateral flow test may detect Alzheimer's decades early

24 Sept 2025

Dried blood spot testing for Alzheimer's biomarker analysis

Dried blood spot testing is revolutionizing Alzheimer’s monitoring

1 Aug 2025

Industry News

Thermo Fisher Scientific enrols first patient in the new PPD CorEvitas Alzheimer’s Disease Registry

6 Jan 2026

Aptamer Group and Neuro-Bio advance Alzheimer’s test and agree royalties

8 May 2025

Spear Bio's pTau 217 blood test earns FDA breakthrough designation

14 Jan 2025

Roche presents new data highlighting advances in Alzheimer’s diagnostics

5 Nov 2024

Latest Videos

Cristiano Tunisi, the Neurology International Business Leader, Roche Diagnostics

How Roche Diagnostics is transforming Alzheimer’s diagnosis with innovative blood-based biomarkers

1 Oct 2025

Beckman Coulter accelerates blood-based Alzheimer’s testing and DxI 9000 expansion

Beckman Coulter accelerates blood-based Alzheimer’s testing

23 Jun 2025

The future of Alzheimer's biomarker testing

The future of Alzheimer's biomarker testing

27 May 2025

Andy Hay, Sysmex America Ltd. and Sonia Nicholas, SelectScience, interview for CLINICAL24

CLINICAL24: Challenges, collaborations, and innovations in hematology

21 Oct 2024

Alzheimers Disease: Find the latest interviews, articles, videos and resources